SCHEDULE 13G/A: CVI Investments and Heights Capital Management Disclose 5.7% Stake in ReShape Lifesciences

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a beneficial ownership of 5.7% in ReShape Lifesciences Inc., primarily through warrants.

Summary

• CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in ReShape Lifesciences Inc.
• The Reporting Persons collectively beneficially own 200,000 shares of ReShape Lifesciences Inc. common stock.
• This ownership represents 5.7% of the company's outstanding common stock.
• The shares beneficially owned consist of shares issuable upon the exercise of warrants to purchase shares.
• The warrants are subject to a limitation, not exercisable to the extent that beneficial ownership would exceed 9.99%.
• Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and may exercise shared voting and dispositive power over the reported shares.
• As of February 18, 2025, ReShape Lifesciences Inc. had 3,305,087 shares outstanding, as reported in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or prospects.

Risks

• The beneficial ownership is derived from warrants, which may introduce dilution risk if exercised, although the document notes a 9.99% beneficial ownership cap on exercise.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of significant beneficial ownership by institutional investors, common across all industries. It does not provide specific insights into broader industry trends for the medical device or weight loss sectors, but rather details an investment firm's stake in a company within that space.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence market perception and trading activity.

Key Dates

Keywords

ReShape Lifesciences, CVI Investments, Heights Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Investment Management, Shareholder Disclosure